Researchers at the Weill Institute for Cell and Molecular Biology have  uncovered new evidence that two major types of ...
Tumor agnostic efficacy and safety of erdafitinib (erda) in patients (pts) with advanced solid tumors with prespecified FGFR alterations (FGFRalt): RAGNAR primary analysis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results